Walgreens ( NASDAQ: WBA) has to consider and evaluate all options as part of its fiduciary duty, CEO Tim Wentworth said in ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...

Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...

Walgreens has faced challenges in its retail segment due to persistent inflation impacting consumer spending and has also struggled with low reimbursement rates in its pharmacy operations. These ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...

Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...

The company was apparently in talks to be acquired by private equity firm Sycamore Partners. CNBC's David Faber reported live and on-air that unnamed sources told him that a looming arrangement ...

Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...